Although the relative contribution of different immune effector functions to clearing tissues of cytomegalovirus is controversial, the contribution of CD8+ T lymphocytes has generally been accepted as essential. In this report, we show that under certain conditions the CD8+ T-lymphocyte subset can be dispensable for clearance of cytomegalovirus. Mice depleted of the CD8+ T-lymphocyte subset eliminated infectious virus with a clearance kinetics similar to that of normal mice. Adoptive transfer studies revealed that the limitation of virus spread required the cooperation between the CD4+ subset and other cells. Comparison between protective functions generated in fully immunocompetent and in CD8-mice demonstrated that elimination of the CD8+ subset before infection altered the quality of the antiviral immune response. The compensatory protective activity gained by CD4+ cells in CD8-mice was absent in normal mice recovering from virus infection.
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Human cytomegalovirus (HCMV), a member of the herpesvirus family, is endemic in all human populations. Similar to other herpesvirus infections, acute HCMV infection is followed by chronic infection or viral latency from which reactivation can occur. Congenital HCMV infection of the immunologically immature fetus represents the most common viral intrauterine infection, and HCMV is also the major cause of viral morbidity and mortality in immunocompromised patients. The status of the immune system dictates whether infection is asymptomatic or leads to clinical or even fatal disease. Since reactivation can also occur in seropositive subjects, cellular immune mechanisms appear to have a major role in HCMV control. Accordingly, the activity of cytolytic T lymphocytes was found to correlate with recovery of transplant patients from primary HCMV infection (26) . The role of CD4+ T lymphocytes and the protective effects of antibodies are not clear. Prophylactic administration of anti-HCMV immunoglobulin can reduce the severity of HCMV disease and has an effect on the incidence of HCMV pneumonitis, whereas therapeutic application has been mainly without protective effects (41) .
To study the immune mechanisms in the infected host, infection of mice with murine cytomegalovirus (MCMV) has been used as a suitable animal model (13) . Evidence has been provided that primed CD8+ T lymphocytes can protect against subsequent lethal MCMV disease (24, 28, 31, 32, 34) . This protective function of the antecedent CD8+ T-lymphocyte activity was documented by cell transfer experiments and by the selective activation of antiviral CD8+ T lymphocytes (8, 14) . The experiments invariably showed that whenever CD8+ T lymphocytes were activated, they played a dominant role in protection. The significance of antibody is not clear, since prophylactic transfer of antiserum to MCMV has protective activity, whereas immunoglobulin therapy of established infection does not prevent viral spread (38) . Similarly, the contribution of sensitized CD4+ T lymphocytes is controversial (28, 36) . These data show clearly that a preceding activation of both cellular and humoral immune * Corresponding author.
functions can contribute to protection against subsequent primary MCMV infection or reinfection.
The relative importance of the different immune effector mechanisms that are generated during primary infection is not revealed by these studies. Therefore, we have started to analyze the contribution of the CD4+ and the CD8+ T-lymphocyte subsets to MCMV clearance. The experimental approach has been the depletion of lymphocyte subsets in vivo before and during infection. We have reported recently that mice can control acute MCMV infection in the absence of the CD4+ subset (15) . CD4-mice clear most infected organs but develop a chronic infection confined to the salivary glands. In the study reported here, we tested the alternative situation. Mice were depleted of the CD8+ T-lymphocyte subset and then infected with MCMV. The results show that recovery from acute MCMV infection can proceed in the absence of the CD8+ T-cell subset. Although virus clearance was almost indistinguishable between normal and CD8-mice, major differences were revealed by the analysis of immune effector functions.
MATERIALS AND METHODS
Elimination of T-lymphocyte subsets in vivo. Female BALB/c mice 4 to 5 weeks of age were thymectomized under chloral hydrate anesthesia according to standard surgical procedures. In vivo depletion of T-lymphocyte subsets was carried out as described by Cobbold et al. (6) . Depletion of the CD8+ subset was accomplished by daily intravenous injections of thymectomized mice (for time schedule, see Fig. 1 ) with 1 mg of rat immunoglobulin G2b (IgG2b) anti-murine CD8 monoclonal antibody (MAb) YTS 169.4 (6) for 3 successive days. After that period, CD8+-depleted mice were injected weekly with 0.25 mg of mouse IgG2a anti-Lyt 2.2 (CD8) MAb 19/178 (10) throughout the experiment. For depletion of CD4+ T lymphocytes, mice were injected intravenously with 1 mg of rat IgG2b anti-mouse CD4 MAb YTS 191.1 (6) for 3 successive days. The antibodies used for in vivo treatment were enriched from ascitic fluid by precipitation with 50% ammonium sulfate and subsequent dialysis against phosphate-buffered saline. The concentration of specific antibody was determined by immunodiffusion, using rat and mouse IgG standards (15) . Monitoring of T-cell subsets. Depletion efficacy of T-lymphocyte subsets in cell suspensions was tested by singleparameter cytofluorometric analysis for the presence of the CD4+ and CD8+ subsets as described previously (15) . The depletion efficacy of T-lymphocyte subsets after treatment with anti-CD4 and anti-CD8 MAb in tissues was tested by indirect immunoperoxidase staining of frozen tissue sections as described by Hsu et al. (12) .
Virus and infection conditions. The Smith strain of MCMV (VR-194; American Type Culture Collection, Rockville, Md.) was propagated in BALB/c mouse embryo fibroblasts as described previously (29) . Mice were infected by injection of 2 x 105 PFU of MCMV into one hind footpad. T-cell subset-depleted mice were infected after the third injection of rat MAb, and recipients for the adoptive transfer were infected 2 h after irradiation and cell transfer.
Determination of virus titers in tissues. MCMV in tissues was quantified by plaque assay (34). The detection limit was 100 PFU of MCMV per organ homogenate. Virus titers (x and y) were regarded as significantly different for P (x versus y) < a = 0.05 (one sided), where P is the observed probability value and a is a selected significance level (Wilcoxon-Mann-Whitney exact rank sum test).
Adoptive lymphocyte transfer. The prophylactic adoptive cell transfer was performed as described previously (34) . Recipient mice were subjected to total-body -y irradiation with 6 Gy 2 h before cell transfer. Donor spleen lymphocytes to be transferred were either used as nonseparated cell suspension or enriched to a purity of more than 95% T lymphocytes by passage through nylon-wool columns. If necessary, T-lymphocyte subsets were depleted by treatment with MAb to CD4 (9) Detection of virus-specific antibodies. An enzyme-linked immunosorbent assay (ELISA) for quantifying MCMV-specific antibodies in sera by using infected mouse embryo fibroblasts as a source of antigens was used (14) . Titers were read from the half-maximal optical density after subtraction of values from control lysates of noninfected fibroblasts.
Tumor transplantation. A/J (H-2a)-derived sarcoma I (Sal) tumor was propagated in ascitic form in A/J mice. Sal expresses major histocompatibility complex (MHC) class I antigens, including Kk, Dd and Ld, but is devoid of class II molecules on the cell surface (7, 40 
RESULTS
Experimental design. The experiments were designed to study the ability of mice to control MCMV infection after ablation of the CD8+ T-lymphocyte subset. Because even fully immunocompetent mice require at least 6 weeks for clearance of tissues from infectious virus and establishment of viral latency, a protocol for efficient long-term depletion of T-lymphocyte subsets was essential. The time schedule for the treatments and assays is outlined in Fig. 1 . In a previous report, we described the course of MCMV infection in long-term CD4-mice (15) . In that study, the state of CD4+ subset deficiency was maintained by weekly injection of rat MAb to murine CD4. Because of the risk of an antiglobulin response to xenogeneic antibodies, this protocol could not be applied to long-term depletion of CD8+ T lymphocytes. Therefore, thymectomized mice were used to prevent the repopulation of peripheral lymphoid organs. Mice were first injected with MAb of rat origin on 3 consecutive days before infection with MCMV. The efficacy of T-cell subset depletion was controlled by cytofluorometry and immunohistology. Whereas a low number of CD8+ T lymphocytes was still detectable in lymphoid tissues 6 weeks after treatment of mice with rat MAb to murine CD8 alone, the number of these residual cells was reduced to the background level by additional weekly injection of murine MAb to CD8 (data not shown). Functional CD8+ T-lymphocyte inactivation was monitored by testing the capacity to generate MCMV-specific CTL and by testing the rejection of an allogeneic tumor graft differing in MHC class I molecules. Thymectomized mice were also depleted of the CD4+ T-lymphocyte subset to provide either CD4-or CD8-mice under conditions that allow comparison between previously published data and the results presented here. The state of MCMV infection in immunosuppressed and control mice was monitored by screening individual mice collected randomly from the respective samples. The antiviral effect of lymphoid cells was tested by adoptive transfer into MCMVinfected syngeneic recipient mice that were immunodepleted by 6 Gy of irradiation (34) . This adoptive transfer regimen was developed previously as a model for cytoimmunoprophylaxis of CMV disease and can be used as an in vivo assay for estimating the strength of the T-lymphocyte-mediated antiviral immunity generated in the donor mice (24, 28, 31, 32, 34) .
Functional depletion of the CD8+ subset in vivo. Immunosuppressed and control mice were infected with MCMV. None of the CD4-mice but also none of the CD8-mice showed signs of illness or succumbed to MCMV infection. Four weeks later, spleen cells were isolated and restimulated with MCMV in vitro, and the generation of a CTL response was tested (Fig. 2) . CTL from both MCMV-primed immunocompetent mice and CD4-mice were able to lyse KD2SV (H-2d) fibroblast targets pulsed with synthetic peptide P(161-179). This peptide represents the epitope recognized by CTL in the immediate-early protein pp89, an immunodominant antigen of MCMV recognized by antiviral CD8+ CTL (8, 14, 16, 17, 30, 33, 42) . In vivo depletion of the CD8+ T-lymphocyte subset abolished generation of the CTL response. (Fig. 3) . Immunocompetent control mice rejected the tumor graft by 20 days after transplantation. The progressive tumor growth observed in the group of CD8-mice and the death of these animals within 5 weeks indicated that the depletion protocol could be used also for long-term functional ablation of CD8+ T lymphocytes.
Clearance of infectious virus in tissues of CD8-mice. The state of infection in T-lymphocyte-subset-depleted mice was studied by measuring infectious virus in organs at different times after infection. CD4-mice exhibit a delayed clearance of the lungs and completely fail to clear the salivary glands, in which a persistent infection is established (15) . As expected, the combination of thymectomy and CD4+ subset depletion led to the same result (Fig. 4) ). The control level (CL) represents the effect seen after transfer of the same number of cells from noninfected, immunocompetent control donors. DL, Detection limit. generated de novo in only sublethally irradiated recipients. As expected, the MAb to CD8 completely eliminated the antiviral effect of cells from CD4-mice, which depend on the function of CD8+ T lymphocytes (Fig. Sb) . Remarkably, the same effect was seen after treatment of mice that had received cells from immunocompetent mice (Fig. 5a) , which demonstrates the major role that CD8+ T lymphocytes play under natural conditions during recovery from MCMV infection. Table 1 shows the effect of lymphocyte subset depletion on the antibody response to MCMV in these mice. After ablation of the CD8+ subset, the recipients of cells from immunocompetent mice still generated the same titer of antibodies, but these antibodies did not mediate virus clearance. Because MAb to CD8 did not abrogate the protective effect of cells from CD8-mice (Fig. 5c) , a dominant function of residual CD8+ T lymphocytes in this test group was unlikely.
Treatment with MAb to murine CD4 provided the appropriate control and showed that the elimination of CD4+ T lymphocytes had little effect on the protective effect of cell populations from immunocompetent ( Fig. Sa) and CD4-mice, (Fig. Sb) although this treatment abolished antibody production in the recipients of cells from nondepleted mice ( Table 1) . Treatment of recipients of cells from CD8-mice with MAb to murine CD4, however, eliminated both the antiviral activity (Fig. Sc) and the capacity to produce antibodies to MCMV (Table 1) . Thus, the CD8-mice harbor The same groups as described in Fig. 5 (12 weeks after infection) . b Serum was taken from the adoptive transfer recipients 2 weeks p.i., and MCMV-specific antibodies were determined by ELISA. Data represent the reciprocal of the serum dilution that gave half-maximal activity.
CD4+ cells, which are essential for the limitation of viral spread in the cell recipients. The fact that this CD4+ cell function is not revealed in immunocompetent mice after depletion of the CD8+ subset indicates a compensatory function of CD4+ cells that is active only in CD8-mice.
No direct antiviral effect of T lymphocytes from CD8-mice. Although the CD4+ subset was essential for the antibody response in cell recipients from all test groups, the capacity of transferred cells to generate antiviral antibodies did not correlate with virus clearance. In addition, only after cell transfer from CD8-mice was the CD4+ subset essential for antiviral activity. Collectively, these data raised the question of a direct antiviral effector activity of the CD4+ subset in CD8-mice. Such an effect has been described for human CD4+ T lymphocytes after elimination of the CD8+ subset (3). To test this possibility, the spleen cells of mice were isolated 10 weeks p.i. and enriched for T lymphocytes. After transfer into irradiated and MCMV-infected recipients, the cells from noninfected donors had no activity (Fig. 6a,  column A) , in contrast to T lymphocytes from primed mice (column B). T lymphocytes from primed CD4-mice (column C) had an activity comparable to that of cells from primed mice (compare column B with column C), whereas T lymphocytes from primed CD8-mice (column D) were without activity. Two conclusions were drawn. First, CD4+ T lymphocytes from CD8-mice have no direct protective effect after transfer. The absence of a direct effector function excluded a contribution of residual CD8+ T lymphocytes to virus clearance by cells from CD8-mice. Second, CD4+ cells from CD8-mice must cooperate with other cells to mediate virus clearance.
DISCUSSION
The aim of this study was to investigate whether in a state of selective CD8+ subset deficiency the immune system can control CMV infection and, if so, how the course of infection (that is, the succession of acute phase, persistent phase, and latent phase of infection) is altered in the absence of the CD8+ subset.
We have tested the recovery of CD8-mice from MCMV infection and report that these mice survive and are even able to control and clear tissues of infectious MCMV. The kinetics of virus clearance was found to be almost indistinguishable from that of fully immunocompetent mice. We have reported previously that mice can effectively control acute MCMV infection in the absence of antibodies and in the absence of CD4+ T-helper functions (15) . The difference that we observed between normal and CD4-mice was that CD4-mice exhibited an altered virus clearance pattern and developed a chronic MCMV infection of the acinar glandular epithelial cells in salivary gland tissue. Because even a low number of CD8+ T lymphocytes can have profound effects on virus clearance, the new finding, namely, that CD8+ T lymphocytes can be negligible, was somewhat disconcerting, and it was important to rigorously exclude the putative contribution of residual CD8+ T lymphocytes. Significant numerical reduction of CD8+ T lymphocytes was achieved by a combination of treatment with rat and mouse MAb specific for the murine CD8 molecule, which led to the efficient long-term removal of antigen-positive cells. The functional absence of MCMV-specific CD8+ T lymphocytes was shown in several independent assays. First, CD8-mice did not generate CTL specific for MCMV. Second, CD8-mice did not reject an allogeneic tumor graft. Third, whereas protective activity in normal and in CD4-mice was associated with a direct function of CD8+ T lymphocytes, this did not apply to T lymphocytes from CD8-mice. Fourth, the protective function of cells from CD8-mice was destroyed by treatment of recipients with antibody to CD4 but not to CD8. Collectively, these data show that the CD8+ subset did not contribute to the virus clearance in CD8-mice. Thus, the first conclusion that can be drawn is that the course of infection is not altered in mice deficient for the CD8+ subset.
The availability of MAb to T-lymphocyte surface molecules has stimulated in vivo and in vitro analyses of antiviral functions of T-lymphocyte subsets (43) . Studies on herpes simplex virus (HSV) (25) , influenza A virus (20) , lymphocytic choriomeningitis virus (LCMV) (1, 18, 22) , ectromelia virus (5) , and MCMV (15, 28, 31, 32, 34) have consistently stressed the importance of the contribution of CD8+ T lymphocytes to virus clearance. However, the relative role of each of the major T-lymphocyte subsets is apparently quite different for each of the virus infections studied. For instance, deletion of the CD4+ T-lymphocyte subset does not prevent the elimination of LCMV (1, 22) or influenza A virus (20) but causes a delayed local clearance of HSV (25) and results in site-restricted persistent MCMV infection (15) . Even more striking are the differences in mice deficient for the CD8+ T-lymphocyte subset: this situation leads to the complete inability to clear LCMV (1, 22) , whereas influenza A virus-infected mice still eliminate the virus (20) , and HSV-infected mice clear the infection of the skin but develop a severe infection of the nervous system (25) (32) . Another CD4+ subset and other cells could be the release of factors resulting in the activation of nonspecific host defense mechanisms, as shown for an HSV-specific CD4+ T-lymphocyte clone (19) . This T-helper cell clone derived from immunocompetent mice could protect mice from fatal infection. This function was associated with the release of lymphokines, including gamma interferon, which in turn increased the virocidal activity of macrophages (35) . Liberation of various lymphokines could also activate other nonspecific host defense mechanisms, such as natural killer cells, that are thought to be important in the early defense of the host against CMV (2, 4, 27, 37, 39) .
Our new observation that the immune response following ablation of either T-lymphocyte subset can still protect against CMV infection may stimulate research into viral antigens essential for stimulation of the CD4+ subset that mediates protection, into the definition of the protective principle resulting from the cooperation between the CD4+ subset and other cells, and into the mechanisms that regulate MCMV control in the immunocompetent host preferentially via the CD8+ subset. Murine CD4+ T-helper lymphocytes can be divided into at least two types (23) . At the clonal level, these T-helper cells exhibit distinct but overlapping functions with regard to lymphokine secretion and cell cooperation. Data indicate that the expansion of distinct CD4+ T-lymphocyte subsets that are correlates of the Thl and Th2 cells defined at the clonal level in vitro can be associated in vivo with control or progression of disease caused by intracellular pathogens (11) . A testable speculation is that the long-term depletion of CD8+ T lymphocytes alters the contribution of the two T-helper cell subsets to the control of MCMV infection.
